
zzso zzso pulmonary disease zzso is highly prevalent and will continue to be an increasing cause of morbidity and mortality zzso COPD is now viewed under a new paradigm as preventable and zzso In addition, it has become accepted that COPD is not solely a pulmonary disease but also one with important measurable systemic zzso It zzso that patients diagnosed with COPD have to be zzso evaluated to determine the extent of disease so that therapy can be adequately zzso We now know that smoking zzso oxygen for zzso patients, lung reduction surgery for selected patients with zzso and zzso ventilation during severe zzso have an impact on zzso The completion of well planned pharmacological trials have shown the importance of patient centered outcomes and the possible impact on mortality and rate of decline of lung zzso This zzso presents an update on the pharmacological therapy of zzso The future for patients with COPD is bright as primary and secondary prevention of smoking becomes more effective and air quality zzso In addition, current research will unravel the zzso clinical and zzso manifestations of COPD thus providing exciting therapeutic zzso Ultimately, the advent of newer and more effective therapies will lead to a decline in the contribution of this disease to poor world zzso 

